Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-26 | Dr. Ferguson graduated in biological sciences from Cornell University, obtained his PhD in pharmacology from the University of Texas Health Sciences Center Dallas, and completed his postdoctoral studies at Cold Spring Harbor Laboratory in New York. |
| 2023-11-14 | Dr. Kenneth M. Ferguson(1) Includes options to purchase 2,637 shares of Common Stock that are exercisable within 60 days of November 6, 2023 and 7,911 Restricted Stock Units that will vest within 60 days of November 6, 2023. |
| 2024-05-08 | Dr. Ferguson graduated in biological sciences from Cornell University, obtained his PhD in pharmacology from the University of Texas Health Sciences Center Dallas, and completed his postdoctoral studies at Cold Spring Harbor Laboratory in New York. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22